BioCentury | Jan 8, 2021
Finance

Venrock stays modest with $450M ninth fund as it continues to seek disruptive, early-stage tech

...will be allocated to healthcare, and the remainder to technology. Recent therapeutics investments include targeted radiotherapy play RayzeBio Inc....
BioCentury | Dec 18, 2020
Product Development

2021 Predictions: a BioCentury survey

...also garnered substantial investor interest. This month, RayzeBio Inc....
BioCentury | Dec 12, 2020
Finance

RayzeBio gets unexpected lift from broad investor appetite for targeted radiotherapies

...Capital.Versant’s Jerel Davis said the firm scouted radiotherapy opportunities for three years before investing in RayzeBio Inc. Versant...
...operations.Bong Koh, the lead investor from Venrock Healthcare Capital Partners, is joining RayzeBio’s board. Karen Tkach Tuzman RayzeBio Inc. radiophramaceuticals radiotherapy targeted...
BioCentury | Oct 15, 2020
Emerging Company Profile

RayzeBio pulling together radiotherapy platform with $45 million

...Song told BioCentury he was drawn to RayzeBio Inc....
Items per page:
1 - 4 of 4
BioCentury | Jan 8, 2021
Finance

Venrock stays modest with $450M ninth fund as it continues to seek disruptive, early-stage tech

...will be allocated to healthcare, and the remainder to technology. Recent therapeutics investments include targeted radiotherapy play RayzeBio Inc....
BioCentury | Dec 18, 2020
Product Development

2021 Predictions: a BioCentury survey

...also garnered substantial investor interest. This month, RayzeBio Inc....
BioCentury | Dec 12, 2020
Finance

RayzeBio gets unexpected lift from broad investor appetite for targeted radiotherapies

...Capital.Versant’s Jerel Davis said the firm scouted radiotherapy opportunities for three years before investing in RayzeBio Inc. Versant...
...operations.Bong Koh, the lead investor from Venrock Healthcare Capital Partners, is joining RayzeBio’s board. Karen Tkach Tuzman RayzeBio Inc. radiophramaceuticals radiotherapy targeted...
BioCentury | Oct 15, 2020
Emerging Company Profile

RayzeBio pulling together radiotherapy platform with $45 million

...Song told BioCentury he was drawn to RayzeBio Inc....
Items per page:
1 - 4 of 4